Patch Test Skin Irritation/Sensitization of Cetaphil Daily Advance Ultra Hydration Lotion

100 Human Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Occlusive Patch)

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01885130

Enrollment

100

Registered

2013-06-24

Start date

2012-12-31

Completion date

Unknown

Last updated

2022-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Determine Sensitivity of Skin to Cetaphil Daily Advance Ultra Hydrating Lotion

Brief summary

Determine if Cetaphil Daily Advance Ultra Hydrating Lotion proves to be a contact sensitizer or irritant in certain individuals.

Interventions

OTHERCetaphil Daily Advance Ultra Hydrating Lotion

0.2ml or 0.2g of Cetaphil on occlusive, hypoallergenic patch applied to skin for 24 hrs 9 times on Monday, Wednesday, and Friday for 3 weeks

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Not currently under a doctor's care * Free of dermatological or systemic disorder which would interfere with the results * Free of any acute or chronic disease * Will complete a preliminary medical history form and are in general good health * Can read, understand, and sign informed consent

Exclusion criteria

* Under 18 years old * Currently under doctor's care * currently taking any medication * History of acute or chronic disease * Diagnosed with chronic skin allergies * Pregnant or lactating

Design outcomes

Primary

Measure	Time frame	Description
area of erythema and edema is measured	3 consecutive weeks	9 consecutive 24hr exposures for every Monday, Wednesday, and Friday for 3 consecutive weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026